“Active” T-cell Rosettes and total T-rosettes in patients with melanoma following intratumoral inoculation of BCG: A clue to the mechanism of action of bacillus calmette-guérin? J. WybranL. E. SpitlerH. H. Fudenberg Original Articles Pages: 153 - 156
Intralesional injection of immunostimulants in rat and mouse tumors J-C. SalomonN. Lynch Original Articles Pages: 145 - 151
Silica abrogation of mycobacterial adjuvant contact suppression of tumor growth in rats and athymic mice D. G. HopperM. V. PimmR. W. Baldwin Original Articles Pages: 143 - 144
Immunologic approaches to the treatment of human cancer based on a guinea pig model B. ZbarE. RibiH. J. Rapp Short Reviews Pages: 127 - 137
Immunodeficiency in cancer patients and immunorestoration M. C. SimmlerM. Bruley-Rosset Short Reviews Pages: 119 - 126
Increase of null cells in patients submitted to long-term active immunotherapy D. BelpommeR. JosephN. Lelarge Letter To CII Pages: 113 - 114
BCG in the immunotherapy of Hodgkin's disease and non-Hodgkin's lymphomas B. HœrniJ. ChauvergneC. Lagarde Short Communication Pages: 109 - 112
Immunotherapy of breast cancer, malignant melanoma, and acute leukemia with BCG: Prolongation of disease free interval and survival J. U. GuttermanG. M. MavligitE. M. Hersh Original Articles Pages: 99 - 107
Present status of BCG immunotherapy of malignant melanoma D. L. MortonF. R. EilberK. P. Ramming Original Articles Pages: 93 - 98
Various uses of BCG and allogeneic acute leukemia cells to treat patients with acute myelogenous leukemia J. A. RussellB. ChapuisR. L. Powles Original Articles Pages: 87 - 91
1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy G. MatheF. de VassalC. Jasmin Original Articles Pages: 77 - 86
Human toxicology of BCG applied in cancer immunotherapy L. SchwarzenbergM. C. SimmlerJ. L. Pico Original Articles Pages: 69 - 76
Toxic effects of massive doses of BCG in mice, guinea pigs, and monkeys V. PortelanceM. QuevillonY. Page Original Articles Pages: 63 - 67
Toxicity studies of intravenously administered BCG in baboons S. Jurczyk-ProcykM. MartinH. Rappaport Original Articles Pages: 55 - 61
The immunoproliferative response of mice to intravenously or subcutaneously injected BCG H. RappaportA. Khalil Original Articles Pages: 45 - 49
Enhancement of T suppressor activity in mice by high doses of BCG M. GeffardS. Orbach-Arbouys Original Articles Pages: 41 - 43
Studies on the mechanisms of action of BCG I. FlorentinR. HuchetG. Mathé Original Articles Pages: 31 - 39
Antitumor activity and other biological properties of two phenotypes isolated from BCG R. TurcotteM. Quevillon Original Articles Pages: 25 - 30
Comparison of various BCG preparations in the EORTC — ICIG experimental screening for systemic immunity adjuvants applicable to cancer immunotherapy O. Halle-PannenkoCh. BourutM. Kamel Original Articles Pages: 17 - 23
Preservation of fresh BCG scarification vaccine at 4, −25, and −70° C M. GheorghiuL. Chambon Original Articles Pages: 11 - 16